- call +1-201-465-4211
- email sales@mrinsights.biz
The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.
Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.
A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."
An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.
Scope of the Report:
This report studies the Artificial Pancreas Device System (APDS) market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Artificial Pancreas Device System (APDS) market by product type and applications/end industries.
The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.
Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.
North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.
Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.
The global Artificial Pancreas Device System (APDS) market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Artificial Pancreas Device System (APDS).
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems
Market Segment by Applications, can be divided into
Hospitals
Clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Artificial Pancreas Device System (APDS) Market Overview
1.1 Product Overview and Scope of Artificial Pancreas Device System (APDS)
1.2 Classification of Artificial Pancreas Device System (APDS) by Types
1.2.1 Global Artificial Pancreas Device System (APDS) Revenue Comparison by Types (2017-2023)
1.2.2 Global Artificial Pancreas Device System (APDS) Revenue Market Share by Types in 2017
1.2.3 Threshold Suspended Device Systems
1.2.4 Hybrid Closed-loop APDS
1.2.5 Other Systems
1.3 Global Artificial Pancreas Device System (APDS) Market by Application
1.3.1 Global Artificial Pancreas Device System (APDS) Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Clinics
1.4 Global Artificial Pancreas Device System (APDS) Market by Regions
1.4.1 Global Artificial Pancreas Device System (APDS) Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Artificial Pancreas Device System (APDS) Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Artificial Pancreas Device System (APDS) Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Artificial Pancreas Device System (APDS) Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Artificial Pancreas Device System (APDS) Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Artificial Pancreas Device System (APDS) Status and Prospect (2013-2023)
1.5 Global Market Size of Artificial Pancreas Device System (APDS) (2013-2023)
2 Manufacturers Profiles
2.1 Medtronic
2.1.1 Business Overview
2.1.2 Artificial Pancreas Device System (APDS) Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Medtronic Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2016-2017)
2.2 Bigfoot Biomedical
2.2.1 Business Overview
2.2.2 Artificial Pancreas Device System (APDS) Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bigfoot Biomedical Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2016-2017)
2.3 Beta Bionics
2.3.1 Business Overview
2.3.2 Artificial Pancreas Device System (APDS) Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Beta Bionics Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2016-2017)
2.4 Admetsys
2.4.1 Business Overview
2.4.2 Artificial Pancreas Device System (APDS) Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Admetsys Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2016-2017)
2.5 Insulet
2.5.1 Business Overview
2.5.2 Artificial Pancreas Device System (APDS) Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Insulet Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2016-2017)
2.6 Tandem Diabetes Care
2.6.1 Business Overview
2.6.2 Artificial Pancreas Device System (APDS) Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Tandem Diabetes Care Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2016-2017)
2.7 Defymed
2.7.1 Business Overview
2.7.2 Artificial Pancreas Device System (APDS) Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Defymed Artificial Pancreas Device System (APDS) Revenue, Gross Margin and Market Share (2016-2017)
3 Global Artificial Pancreas Device System (APDS) Market Competition, by Players
3.1 Global Artificial Pancreas Device System (APDS) Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Artificial Pancreas Device System (APDS) Players Market Share
3.2.2 Top 10 Artificial Pancreas Device System (APDS) Players Market Share
3.3 Market Competition Trend
4 Global Artificial Pancreas Device System (APDS) Market Size by Regions
4.1 Global Artificial Pancreas Device System (APDS) Revenue and Market Share by Regions
4.2 North America Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
4.3 Europe Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
4.5 South America Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
5 North America Artificial Pancreas Device System (APDS) Revenue by Countries
5.1 North America Artificial Pancreas Device System (APDS) Revenue by Countries (2013-2018)
5.2 USA Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
5.3 Canada Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
5.4 Mexico Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
6 Europe Artificial Pancreas Device System (APDS) Revenue by Countries
6.1 Europe Artificial Pancreas Device System (APDS) Revenue by Countries (2013-2018)
6.2 Germany Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
6.3 UK Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
6.4 France Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
6.5 Russia Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
6.6 Italy Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Artificial Pancreas Device System (APDS) Revenue by Countries
7.1 Asia-Pacific Artificial Pancreas Device System (APDS) Revenue by Countries (2013-2018)
7.2 China Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
7.3 Japan Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
7.4 Korea Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
7.5 India Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
8 South America Artificial Pancreas Device System (APDS) Revenue by Countries
8.1 South America Artificial Pancreas Device System (APDS) Revenue by Countries (2013-2018)
8.2 Brazil Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
8.3 Argentina Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
8.4 Colombia Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Artificial Pancreas Device System (APDS) by Countries
9.1 Middle East and Africa Artificial Pancreas Device System (APDS) Revenue by Countries (2013-2018)
9.2 Saudi Arabia Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
9.3 UAE Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
9.4 Egypt Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
9.5 Nigeria Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
9.6 South Africa Artificial Pancreas Device System (APDS) Revenue and Growth Rate (2013-2018)
10 Global Artificial Pancreas Device System (APDS) Market Segment by Type
10.1 Global Artificial Pancreas Device System (APDS) Revenue and Market Share by Type (2013-2018)
10.2 Global Artificial Pancreas Device System (APDS) Market Forecast by Type (2018-2023)
10.3 Threshold Suspended Device Systems Revenue Growth Rate (2013-2023)
10.4 Hybrid Closed-loop APDS Revenue Growth Rate (2013-2023)
10.5 Other Systems Revenue Growth Rate (2013-2023)
11 Global Artificial Pancreas Device System (APDS) Market Segment by Application
11.1 Global Artificial Pancreas Device System (APDS) Revenue Market Share by Application (2013-2018)
11.2 Artificial Pancreas Device System (APDS) Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Clinics Revenue Growth (2013-2018)
12 Global Artificial Pancreas Device System (APDS) Market Size Forecast (2018-2023)
12.1 Global Artificial Pancreas Device System (APDS) Market Size Forecast (2018-2023)
12.2 Global Artificial Pancreas Device System (APDS) Market Forecast by Regions (2018-2023)
12.3 North America Artificial Pancreas Device System (APDS) Revenue Market Forecast (2018-2023)
12.4 Europe Artificial Pancreas Device System (APDS) Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Artificial Pancreas Device System (APDS) Revenue Market Forecast (2018-2023)
12.6 South America Artificial Pancreas Device System (APDS) Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Artificial Pancreas Device System (APDS) Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Artificial Pancreas Device System (APDS) Picture
Table Product Specifications of Artificial Pancreas Device System (APDS)
Table Global Artificial Pancreas Device Sys
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
